v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 683,610 $ 359,121
Accounts receivable, net 345,684 358,640
Inventory, net 64,212 64,674
Income tax receivable 0 15,387
Other current assets 30,204 21,400
Assets held for sale 0 80,742
Total current assets 1,123,710 899,964
Investment in equity securities 98,427 42,213
Long-term notes receivable 25,297 0
Property, plant and equipment, net 149,627 163,686
Intangibles, net 641,612 722,779
Goodwill 238,626 239,517
Deferred tax assets, net 121,135 109,196
Other long-term assets 57,699 50,044
Total assets 2,456,133 2,227,399
Current liabilities:    
Current portion of long-term debt and other borrowings 605 738
Accounts payable 47,700 42,906
Accrued expenses and other liabilities 297,662 267,307
Liabilities held for sale 0 22,468
Total current liabilities 345,967 333,419
Asset retirement obligations 257 138
Long-term debt and other borrowings, net of current portion 571,136 568,678
Long-term deferred tax liabilities 41,136 54,246
Long-term contingent consideration liabilities, net of current portion 51,657 73,255
Other long-term liabilities 90,268 107,866
Total liabilities 1,100,421 1,137,602
Commitments and contingencies (Note 15)
Stockholders' equity:    
Preferred stock ($0.01 par value, 25,000 shares authorized; no shares issued and outstanding) 0 0
Common stock ($0.01 par value; 250,000 shares authorized; 72,614 and 71,827 shares issued; 65,373 and 64,586 shares outstanding at September 30, 2026, and December 31, 2025, respectively) 726 718
Additional paid-in capital 939,321 888,320
Treasury stock at cost; 7,241 shares at September 30, 2026 and December 31, 2025 (477,438) (477,438)
Retained earnings 895,321 679,504
Accumulated other comprehensive loss (2,218) (1,307)
Total stockholders’ equity 1,355,712 1,089,797
Total liabilities and stockholders’ equity $ 2,456,133 $ 2,227,399